Bellwether Advisors’s Quest Diagnostics DGX Stock Holding History

Bellwether Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75	Closed	-$13.5K	–	246
2025 Q2	$13.5K	Hold	75	–	–	﹤0.01%	339
2025 Q1	$12.7K	Hold	75	–	–	﹤0.01%	304
2024 Q4	$11.3K	Buy	+75	New	+$11.7K	﹤0.01%	330
2023 Q2	–	Sell	-75	Closed	-$10.6K	–	179
2023 Q1	$10.6K	Hold	75	–	–	﹤0.01%	275
2022 Q4	$11.7K	Hold	75	–	–	﹤0.01%	261
2022 Q3	$9K	Hold	75	–	–	﹤0.01%	268
2022 Q2	$9K	Hold	75	–	–	﹤0.01%	251
2022 Q1	$10K	Hold	75	–	–	﹤0.01%	308
2021 Q4	$12K	Hold	75	–	–	﹤0.01%	314
2021 Q3	$10K	Hold	75	–	–	﹤0.01%	304
2021 Q2	$9K	Sell	75 -25	-25%	-$3.27K	﹤0.01%	273
2021 Q1	$12K	Hold	100	–	–	﹤0.01%	235
2020 Q4	$11K	Buy	+100	New	+$12.2K	﹤0.01%	228

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bellwether Advisors's DGX Position: Q3 2025 in Review

Bellwether Advisors sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 75 shares — an estimated $13.5K sold.

Bellwether Advisors first reported a position in DGX in Q4 2020 and held it in 13 quarters. The position peaked at $13.5K in Q2 2025. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Bellwether Advisors reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
Bellwether Advisors sold 75 Quest Diagnostics shares in Q3 2025, an estimated $13.5K.
Bellwether Advisors first reported a position in Quest Diagnostics in Q4 2020 and held it in 13 quarters.
Bellwether Advisors's Quest Diagnostics position peaked at $13.5K in Q2 2025.
1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.